The goal of the Cell Separation and Culture Core is to provide services that are frequently utilized by numerous funded investigators so that we may share resources and reduce costs. The core facility also provides the center members with an environment to promote scientific collaboration. In this application, we will continue the services from the Cell Separation and Culture Core for hepatocyte isolation and culturing and liver and immune cell sorting. In addition, we plan to expand our service by developing new techniques to meet the growing demand of the center members, such as establishing hepatocyte cell lines stably expressing Cas9 to enable the use of CASPR gene deletion system as well as isolation of liver progenitors and culturing of iPS cells to support the ever growing field of liver stem cells. To accomplish these goals, we have the following aims: 1) We will continue to provide high quality, consistent services needed by a large number of independently funded investigators to improve research efficiency by sharing resources and lowering costs. 2) We will foster an environment for interdisciplinary collaboration and growth. 3) We will provide training for investigators at USC and elsewhere in techniques for cell isolation and separation. 4) We will develop new services that the funded investigators and junior faculty will likely use in the future to advance their research in the diagnosis, prevention and treatment of livers diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK048522-23
Application #
9414648
Study Section
Special Emphasis Panel (ZDK1)
Project Start
Project End
Budget Start
2018-03-01
Budget End
2019-02-28
Support Year
23
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
DUNS #
072933393
City
Los Angeles
State
CA
Country
United States
Zip Code
90089
Nakamura, Brooke N; Glazier, Alison; Kattah, Michael G et al. (2018) A20 regulates canonical wnt-signaling through an interaction with RIPK4. PLoS One 13:e0195893
Guo, Hao; Lee, Changrim; Shah, Mihir et al. (2018) A novel elastin-like polypeptide drug carrier for cyclosporine A improves tear flow in a mouse model of Sjögren's syndrome. J Control Release 292:183-195
Wu, Raymond; Murali, Ramachandran; Kabe, Yasuaki et al. (2018) Baicalein Targets GTPase-Mediated Autophagy to Eliminate Liver Tumor-Initiating Stem Cell-Like Cells Resistant to mTORC1 Inhibition. Hepatology 68:1726-1740
Ogasawara, Noriko; Poposki, Julie A; Klingler, Aiko I et al. (2018) IL-10, TGF-?, and glucocorticoid prevent the production of type 2 cytokines in human group 2 innate lymphoid cells. J Allergy Clin Immunol 141:1147-1151.e8
Edman, Maria C; Janga, Srikanth R; Meng, Zhen et al. (2018) Increased Cathepsin S activity associated with decreased protease inhibitory capacity contributes to altered tear proteins in Sjögren's Syndrome patients. Sci Rep 8:11044
Baulies, Anna; Montero, Joan; Matías, Nuria et al. (2018) The 2-oxoglutarate carrier promotes liver cancer by sustaining mitochondrial GSH despite cholesterol loading. Redox Biol 14:164-177
Ju, Yaping; Janga, Srikanth Reddy; Klinngam, Wannita et al. (2018) NOD and NOR mice exhibit comparable development of lacrimal gland secretory dysfunction but NOD mice have more severe autoimmune dacryoadenitis. Exp Eye Res 176:243-251
Peddi, Santosh; Pan, Xiaoli; MacKay, John Andrew (2018) Intracellular Delivery of Rapamycin From FKBP Elastin-Like Polypeptides Is Consistent With Macropinocytosis. Front Pharmacol 9:1184
Zhou, Beiyun; Flodby, Per; Luo, Jiao et al. (2018) Claudin-18-mediated YAP activity regulates lung stem and progenitor cell homeostasis and tumorigenesis. J Clin Invest 128:970-984
Khanova, Elena; Wu, Raymond; Wang, Wen et al. (2018) Pyroptosis by caspase11/4-gasdermin-D pathway in alcoholic hepatitis in mice and patients. Hepatology 67:1737-1753

Showing the most recent 10 out of 449 publications